Cancer drugs - A pratical approach to drugs available to us

Edition en anglais

Note moyenne 
Jean Trédaniel - Cancer drugs - A pratical approach to drugs available to us.
What do doxorubicin and adriamycin have in common? Why can the indications for platinum compounds vary so much? Have monoclonal antibodies ousted cytotoxic... Lire la suite
35,00 € Neuf
Expédié sous 7 à 15 jours
Livré chez vous entre le 8 juin et le 17 juin
En librairie

Résumé

What do doxorubicin and adriamycin have in common? Why can the indications for platinum compounds vary so much? Have monoclonal antibodies ousted cytotoxic drugs? What is an anticancer antibiotic? The aim of this book is to answer these questions, and all those that arise from being in contact with cancer drugs. To do this, we first need to classify each one in relation to the others. Each product is then described, detailing its official indications, as validated by its marketing license, then its dose, its mode of administration and the precautions that need to be taken when using it, any eventual resistance it may generate, and finally, the side effects it may cause.

Caractéristiques

  • Date de parution
    03/03/2014
  • Editeur
  • ISBN
    978-2-7472-2044-6
  • EAN
    9782747220446
  • Présentation
    Broché
  • Poids
    0.578 Kg
  • Dimensions
    16,0 cm × 24,0 cm × 1,9 cm

Avis libraires et clients

À propos de l'auteur

Biographie de Jean Trédaniel

Jean TREDANIEL is a Professor of Oncology at Paris-Descartes University. He leads the thoracic cancerology unit of the Paris Saint-Joseph Hospital Group.

Du même auteur

Les clients ont également aimé

Derniers produits consultés

Decitre utilise des cookies pour vous offrir le meilleur service possible. En continuant votre navigation, vous en acceptez l'utilisation. En savoir plus OK
35,00 €